MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
2.170
+0.010 (0.46%)
Dec 20, 2024, 4:00 PM EST - Market closed
MediciNova Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MediciNova stock has a target of 9.00, which predicts an increase of 314.75% from the current stock price of 2.17.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for MediciNova is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +314.75% | Dec 6, 2024 |
D. Boral Capital | D. Boral Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +314.75% | Dec 2, 2024 |
Maxim Group | Maxim Group | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +591.24% | Mar 10, 2021 |
B. Riley Securities | B. Riley Securities | Strong Buy Maintains $22 → $11 | Strong Buy | Maintains | $22 → $11 | +406.91% | Mar 13, 2020 |
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +913.82% | Mar 25, 2019 |
Financial Forecast
Revenue This Year
n/a
from 1.00M
Revenue Next Year
n/a
EPS This Year
-0.23
from -0.17
EPS Next Year
-0.24
from -0.23
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -0.24 | -0.25 | -0.25 | |||
Avg | -0.23 | -0.24 | -0.24 | |||
Low | -0.23 | -0.24 | -0.24 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.